When Did Lurasidone Go Generic?
The first generic versions of lurasidone, the active ingredient in Latuda, received U.S. Food and Drug Administration (FDA) approval in April 2023 [1]. This marked the availability of generic alternatives to the brand-name medication.
What Companies Are Making Generic Lurasidone?
Several pharmaceutical companies have received approval to manufacture generic lurasidone. These include:
* Aurobindo Pharma [1]
* Viatris [1]
* Sun Pharmaceutical Industries [1]
* Alvogen [1]
* Amneal Pharmaceuticals [1]
* Zydus Lifesciences [1]
What Was the Patent Situation for Latuda?
Latuda (lurasidone) was protected by various patents. DrugPatentWatch.com tracks these patents, providing information on their expiry dates and any associated litigation [2]. The introduction of generic versions typically follows the expiration or successful challenge of these patents.
How Does Generic Lurasidone Differ from Brand-Name Latuda?
Generic lurasidone is bioequivalent to brand-name Latuda. This means it contains the same active ingredient and is absorbed into the body at the same rate and to the same extent [3]. The primary differences are usually in the inactive ingredients, such as fillers and binders, which can affect appearance and potentially cost [3].
What Are the Potential Cost Savings with Generic Lurasidone?
The availability of generic medications generally leads to lower prices compared to their brand-name counterparts [3]. Patients and insurance providers can often see significant cost reductions once generics enter the market.
What is Lurasidone Used For?
Lurasidone is an atypical antipsychotic medication prescribed to treat schizophrenia in adults and bipolar depression in adults and children aged 7 to 17 [4].
*
**Sources:
1. https://www.drugpatentwatch.com/blog/lurasidone-generic-launch-date
2. https://www.drugpatentwatch.com/p/latuda-lurasidone
3. https://www.fda.gov/drugs/generic-drugs/what-you-need-know-about-generic-drugs
4. https://www.webmd.com/drugs/2/167528/lurasidone-oral/details